Thermo Fisher to buy transplant diagnostics firm for $925 million
Life sciences tools maker Thermo Fisher Scientific Inc will buy privately held transplant diagnostics firm One Lambda for $925 million in cash.
Thermo Fisher Scientific, the world leader in serving science, and Life Technologies Corporation, a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close.